Literature DB >> 3723498

C-reactive protein: a marker for disease activity in ankylosing spondylitis and Reiter's syndrome.

D J Nashel, D L Petrone, C C Ulmer, A J Sliwinski.   

Abstract

Forty-four patients, 22 with ankylosing spondylitis (AS) and 22 with Reiter's syndrome (RS) were studied to determine the reliability of C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR) as indicators of disease activity. CRP levels were significantly elevated in patients with active disease for both AS and RS while ESR values for active and inactive disease were not statistically different. Misdiagnosis was more likely when ESR rather than CRP was used as the variable for activity. CRP as measured by nephelometry is a more sensitive and specific indicator of disease activity in AS and RS than ESR.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723498

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Serum secretory immunoglobulins in ankylosing spondylitis.

Authors:  D Wendling; J M Didier; E Seilles
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

2.  Immunoglobulin A and C reactive protein levels in ankylosing spondylitis.

Authors:  A Collado; R Sanmarti; M A Brancós; E Kanterewicz; T Gallart; J Rotés-Querol; A Cobos
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

3.  Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment.

Authors:  H G Taylor; E J Beswick; P T Dawes
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

4.  Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobin.

Authors:  T L Reynolds; M A Khan; S van der Linden; R P Cleveland
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

5.  Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.

Authors:  K M Sanders; A Hertzman; M R Escobar; B H Littman
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.